SHAREHOLDERS AGREEMENTShareholders Agreement • March 31st, 2011 • Rosetta Genomics Ltd. • Pharmaceutical preparations
This Shareholders Agreement (the “Agreement”) is entered into as of the 25th day of November 2010, by and among Rosetta Genomics Ltd. (“Genomics”) and Plan B Ventures I LLC (“Plan B”) (each of Genomics and Plan B may be referred to as a “Shareholder” and collectively referred to as the “Shareholders”).
SETTLEMENT AGREEMENT AND MUTUAL RELEASESettlement Agreement • March 31st, 2011 • Rosetta Genomics Ltd. • Pharmaceutical preparations • New York
This Settlement Agreement is made and entered into as of November 22, 2010 (the “Effective Date”), by and among: (1) on the one hand, Rosetta Genomics Ltd., a corporation organized under the laws of Israel and with its principal place of business at 10 Plaut Street, Rehovot, Israel, 76706 and Rosetta Genomics Inc., a Delaware corporation with its principal place of business at 3711 Market Street, Suite 740, Philadelphia, PA, 19104 (for purposes of this Settlement Agreement, Rosetta Genomics Ltd. and Rosetta Genomics Inc. shall be defined collectively as “Rosetta”); and (2) on the other hand, Prometheus Laboratories Inc. (“Prometheus”), a California corporation with its principal place of business at 9410 Carroll Park Drive, San Diego, California, 92121, USA. Rosetta and Prometheus are at times jointly referred to herein as the “Parties” and each as a “Party.”
